BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21664032)

  • 1. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
    Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
    Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-factor-bearing microparticles (MPs-TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs-TF generation.
    Świtońska M; Słomka A; Sinkiewicz W; Żekanowska E
    Eur J Neurol; 2015 Feb; 22(2):395-401, e28-9. PubMed ID: 25370815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model].
    Luo JG; Chen YD; Tian F; Wang CH; Lü Y; Yang XX; Lü SZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1113-8. PubMed ID: 20193184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
    Xu P; Qi XY; Li CH; Zhang JH; Liu DM; Liu J; Wang WL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
    Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
    Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
    Bajaj MS; Ghosh M; Bajaj SP
    J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Nov; 102(5):945-50. PubMed ID: 19888533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
    Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I
    Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.